Intercept Pharmaceuticals has pulled obeticholic acid (Ocaliva) from the U.S. market as a treatment for primary biliary ...

Intercept Pharmaceuticals has voluntarily pulled Ocaliva (obeticholic acid) from the US market following a request from the ...

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its ...

Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary ...

Primary sclerosing cholangitis is a rare liver complication that can develop among people with inflammatory bowel disease. Early diagnosis can help, but there’s no cure.

Primary sclerosing cholangitis is a rare, unpreventable liver complication that can happen among people with inflammatory bowel disease.

Topline data were announced from a phase 2b/3 trial evaluating saroglitazar in patients with PBC who had an inadequate response or intolerance to UDCA.

Discover a study exploring how verbal instructions and symptom expectations influence fatigue and motivation in people living with primary biliary cholangitis.

The prevalence of chronic and high-impact chronic pain increased significantly in US adults from 2019 to 2023, with long COVID accounting for approximately 13% of both increases, new research showed. ...

A chronic lung disease is a type of disease that prevents the lungs and respiratory system from working correctly. The main job of the respiratory system is to take in oxygen from the air we breathe ...

BE INFECTED. NOW THAT HUNTING SEASON IS IN FULL SWING, OKLAHOMA WILDLIFE IS ASKING FOR THE HELP OF HUNTERS TO TRACK THE SPREAD OF CHRONIC WASTING DISEASE FOUND IN DEER AND ELK. THIS WEEK, THE STATE ...